Kalvista Pharmaceuticals Inc (KALV)
SBC to Revenue
0.00%
Quarterly · Period ending:
KALV SBC to Revenue
Latest reported0.00%period ending
Latest reported0.00%period ending
KALV Quarterly SBC/Revenue (16.08% → 0.00%)
Latest values, visible window
High-resolution chart · PNG
KALV sbc to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SBC to Revenue |
|---|---|
| 0% | |
| 0% | |
| 0% | |
| 377.209% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 28.5042% | |
| 71.1477% | |
| 29.6429% | |
| 31.8789% | |
| 28.9132% | |
| 20.4884% | |
| 17.4535% | |
| 9.333% | |
| 5.8058% | |
| 12.2265% | |
| 24.2236% | |
| 230.2083% | |
| 145.614% | |
| -0.027% | |
| 0% | |
| 4,457.1429% | |
| 5,257.1429% | |
| 4,262.5% | |
| 4,128.5714% | |
| 528.5714% | |
| 1,685.7143% | |
| 2,162.5% | |
| 990% | |
| 1,000% | |
| 983.3333% | |
| 16.0804% |